Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

2 results

Results by year

Filters applied: . Clear all
Page 1
The Utilization of Low Dose Naltrexone for Chronic Pain.
Poliwoda S, Noss B, Truong GTD, Creech ZA, Koushik SS, Urits I, Viswanath O. Poliwoda S, et al. CNS Drugs. 2023 Aug;37(8):663-670. doi: 10.1007/s40263-023-01018-3. Epub 2023 Jul 28. CNS Drugs. 2023. PMID: 37505425
Naltrexone is a mu-opioid receptor antagonist with a long half-life compared with naloxone. Both of these drugs, along with others, were developed with the intention of reversing the effects of opioid abuse or toxicity. Evidence has also shown that nal …
Naltrexone is a mu-opioid receptor antagonist with a long half-life compared with naloxone. Both of these drugs, along with ot …
Identification of a novel opioid, N-piperidinyl etonitazene (etonitazepipne), in patients with suspected opioid overdose.
Calello DP, Aldy K, Jefri M, Nguyen TT, Krotulski A, Logan B, Brent J, Wax P, Walton S, Manini AF; ToxIC Fentalog Study Group. Calello DP, et al. Clin Toxicol (Phila). 2022 Sep;60(9):1067-1069. doi: 10.1080/15563650.2022.2084406. Epub 2022 Jun 16. Clin Toxicol (Phila). 2022. PMID: 35708103 Free PMC article.
Data collected included reported substance use, clinical course, naloxone dose and response, outcome, and analytes detected in biological samples. ...Two of three received subsequent doses for recurrence of opioid toxicity (0.4-0.6 mg IV). One p …
Data collected included reported substance use, clinical course, naloxone dose and response, outcome, and analytes detected in …